Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
On the 1st of April India observed the foundation day of the Reserve Bank of…
Nuclear Energy plays an important role in India's electricity production. It is one of the…
The Coastal State of India Andhra Pradesh is set for the major administrative transformation as…
For the major leap in the advanced technology as the Andhra Pradesh will launch the…
The International Booker Prize 2026 has shortlisted the books and this are featuring the six…
April, starting month of the financial year, has many national and international events. From cultural…